Literature DB >> 26205901

The Fate of Exogenous Human HSP70 Introduced into Animal Cells by Different Means.

Marina Yurinskaya, Olga G Zatsepina, Maxim G Vinokurov, Natalia V Bobkova, David G Garbuz, Alexei V Morozov, Dina A Kulikova, Vladimir A Mitkevich, Alexander A Makarov, Sergei Yu Funikov, Michael B Evgen'ev1.   

Abstract

Over the last decade, it has become evident that in mammals, including humans, heat shock protein 70 (HSP70), apart from its intracellular localization, is found in extracellular space, where it may execute various protective functions. Furthermore, the upregulation of HSP70 family members can be beneficial in the prevention and treatment of various human neurodegenerative diseases and cancer. Here, we demonstrate that recombinant human HSP70 after intranasal administration can penetrate various brain regions of mice in its native form and subsequently undergo rapid degradation. It was also shown that labeled HSP70 added to culture medium of different human and mouse cell lines enters the cells with strikingly different kinetics, which positively correlates with the basic levels of membrane bound Toll-like receptors (TLR) that are characteristic of these cell lines. HSP70 administration does not significantly modulate the level of TLR expression at the protein or RNA level. The degradation of the introduced recombinant HSP70 after entering the cells is likely proteasome-dependent and varies significantly depending on the cells type and origin. These results should be considered when developing HSP70-based therapies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26205901     DOI: 10.2174/1567201812666150724094207

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  8 in total

1.  Interplay between recombinant Hsp70 and proteasomes: proteasome activity modulation and ubiquitin-independent cleavage of Hsp70.

Authors:  Alexey V Morozov; Tatiana M Astakhova; David G Garbuz; George S Krasnov; Natalia V Bobkova; Olga G Zatsepina; Vadim L Karpov; Michail B Evgen'ev
Journal:  Cell Stress Chaperones       Date:  2017-04-26       Impact factor: 3.667

2.  Exogenous heat shock protein HSP70 reduces response of human neuroblastoma cells to lipopolysaccharide.

Authors:  M M Yurinskaya; S Y Funikov; M B Evgen'ev; M G Vinokurov
Journal:  Dokl Biochem Biophys       Date:  2016-09-07       Impact factor: 0.788

3.  Encapsulated Hsp70 decreases endotoxin-induced production of ROS and TNFα in human phagocytes.

Authors:  M M Yurinskaya; O Yu Kochetkova; L I Shabarchina; O Yu Antonova; A V Suslikov; M B Evgen'ev; M G Vinokurov
Journal:  Cell Stress Chaperones       Date:  2016-10-26       Impact factor: 3.667

4.  Exogenous Hsp70 delays senescence and improves cognitive function in aging mice.

Authors:  Natalia V Bobkova; Mikhail Evgen'ev; David G Garbuz; Alexei M Kulikov; Alexei Morozov; Alexander Samokhin; Dmitri Velmeshev; Natalia Medvinskaya; Inna Nesterova; Andrew Pollock; Evgeny Nudler
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-14       Impact factor: 11.205

Review 5.  Heat shock proteins: a history of study in Russia.

Authors:  Mikhail Borisovich Evgen'ev
Journal:  Cell Stress Chaperones       Date:  2021-06-28       Impact factor: 3.667

Review 6.  Role of a Heat Shock Transcription Factor and the Major Heat Shock Protein Hsp70 in Memory Formation and Neuroprotection.

Authors:  Olga G Zatsepina; Michael B Evgen'ev; David G Garbuz
Journal:  Cells       Date:  2021-06-29       Impact factor: 6.600

7.  HSP70 Ameliorates Septic Lung Injury via Inhibition of Apoptosis by Interacting with KANK2.

Authors:  Qing Pei; Wei Ni; Yihang Yuan; Jing Yuan; Xiong Zhang; Min Yao
Journal:  Biomolecules       Date:  2022-03-07

8.  Exogenous recombinant Hsp70 mediates neuroprotection after photothrombotic stroke.

Authors:  S Demyanenko; V Nikul; S Rodkin; A Davletshin; M B Evgen'ev; D G Garbuz
Journal:  Cell Stress Chaperones       Date:  2020-09-01       Impact factor: 3.667

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.